Skip to content

Human Phototoxicity Test

Human Phototoxicity Test

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02751541
Enrollment
35
Registered
2016-04-26
Start date
2016-05-02
Completion date
2016-05-06
Last updated
2018-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sunscreening Agents

Brief summary

To determine the phototoxic potential of a topically applied article in human subjects.

Interventions

DRUGSunscreen Sport Spray (BAY987519)

50 μl/cm\*2 or 0.05 gm/cm\*2 of each test product is applied to duplicate skin sites (approximately 2 x 2 cm each). After the test articles have dried for 5 to 15 min, the sites are covered by the appropriate patch.24 hours later, the set of patches covering the product are removed. Three (3) μl/ cm2 or 0.003 gm/cm\*2 of the test product is reapplied to the test site, air dried for 5 to 15 minutes for volatilization and then the test site is exposed to UVA radiation.(Formulation number - RB#Y51-002)

This site is patched without treatment as irradiated control.

Sponsors

Bayer
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Be male or female between the ages of 18 and 60 inclusive; * Be lightly pigmented (Fitzpatrick Skin Type I, II, III); * Have read and signed the written Informed Consent Form and have completed a HIPAA Authorization Form in conformance with 45CFR Parts 160 and 164; * Be in general good health as determined by the subject's medical history and in the discretion of the investigator.

Exclusion criteria

* Have a visible sunburn; * Have a history of sun hypersensitivity/photosensitivity or photosensitive dermatoses; * Must not have a known sensitivity or allergy against any of the active and non-active ingredients of the test product. * Have a history of allergies or sensitivities to cosmetics, toiletries or any dermatological products.

Design outcomes

Primary

MeasureTime frame
Intensity of skin reactions will be evaluated using 5 point grading scale.Up to 48 hours

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026